![Senthil Sundaram](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Senthil Sundaram
Geen lopende functies
Profiel
Senthil Sundaram held several positions in the pharmaceutical industry, including Chief Executive Officer & Director at Terns Pharmaceuticals, Inc., Vice President & Head-Business Development at Intercept Pharmaceuticals, Inc., and CFO & Principal Accounting Officer at Nightstar Therapeutics Ltd. He also served as an Independent Director at Sio Gene Therapies, Inc. and Social Capital Suvretta Holdings Corp.
I.
Sundaram received his undergraduate degree from Brown University.
Eerdere bekende functies van Senthil Sundaram
| Bedrijven | Functie | Einde |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Algemeen Directeur | 03-08-2023 |
| SIO GENE THERAPIES INC. | Directeur/Bestuurslid | 05-04-2023 |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Directeur/Bestuurslid | 07-06-2019 |
| NIGHTSTAR THERAPEUTICS PLC | Financieel Directeur/CFO | 07-06-2019 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2017 |
Opleiding van Senthil Sundaram
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
56
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Social Capital Suvretta Holdings Corp. I
 Social Capital Suvretta Holdings Corp. I Financial ConglomeratesFinance Operates as blank check company | Finance |
